Valproic acid alleviates generalized hyperalgesia in mice with induced adenomyosis
article
OA: closed
CC0
⤵ 40 in-corpus citations
AI-generated summary
Valproic acid and progesterone treatments improved generalized hyperalgesia in mice with induced adenomyosis, with some indication of reduced myometrial infiltration.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Emerging evidence suggests that adenomyosis, like endometriosis, may also be an epigenetic disease. In this study, we evaluated the effect of valproic acid (VPA) in ICR mice with adenomyosis, induced by neonatal dosing with tamoxifen. For all mice, we evaluated the bodyweight and the response to thermal stimuli by hotplate and tail-flick tests 4, 8, and 12 weeks after dosing, respectively, and then treated mice with low- and high-dose of VPA, progesterone (P4), P4 + VPA, or vehicle only. Three weeks after treatment, both bodyweight and thermal response tests were evaluated again before sacrifice, and the depth of myometrial infiltration was evaluated. We found that: (i) the induction of adenomyosis resulted in progressive generalized hyperalgesia as measured by hotplate and tail-flick tests, along with decreased bodyweight; (ii) treatment with VPA, P4, or a combination was efficacious in improving generalized hyperalgesia; and (iii) drug treatment appeared to reduce the myometrial infiltration, but the difference did not reach statistical significance. Thus, VPA seems to be a promising therapeutics for treating adenomyosis, as reported recently in some case series in humans.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (49)
- Adenomyosis via openalex
- Adenomyosis—A Result of Disordered Stromal Differentiation via openalex
- Animal model of uterine adenomyosis: induction of the lesion in rats by ectopic pituitary isografting. via openalex
- A pilot study on the off-label use of valproic acid to treat adenomyosis via openalex
- Bowel endometriosis: CT-enteroclysis via openalex
- Constitutive and Tumor Necrosis Factor-Alpha-Stimulated Activation of Nuclear Factor-KappaB in Immortalized Endometriotic Cells and Their Suppression by Trichostatin A via openalex
- Duration of dysmenorrhoea and extent of adenomyosis visualised by magnetic resonance imaging via openalex
- Elevated immunoreactivity to tissue factor and its association with dysmenorrhea severity and the amount of menses in adenomyosis via openalex
- Endometriosis via openalex
- Experimental adenomyosis via openalex
- Immunoreactivity of oxytocin receptor and transient receptor potential vanilloid type 1 and its correlation with dysmenorrhea in adenomyosis via openalex
- Inhibition of Proliferation of Endometrial Stromal Cells by Trichostatin A, RU486, CDB-2914, N-Acetylcysteine, and ICI 182780 via openalex
- Mechanisms of Development of Prolactin-Induced Adenomyosis in Mice via openalex
- Medical and surgical management of adenomyosis via openalex
- Neonatal tamoxifen treatment of mice leads to adenomyosis but not uterine cancer via openalex
- Persistence of dysmenorrhea and nonmenstrual pain after optimal endometriosis surgery may indicate adenomyosis via openalex
- Progestins for symptomatic endometriosis: a critical analysis of the evidence via openalex
- Promoter Hypermethylation of Progesterone Receptor Isoform B (PR-B) in Adenomyosis and Its Rectification by a Histone Deacetylase Inhibitor and a Demethylation Agent via openalex
- Promoter Hypermethylation of Progesterone Receptor Isoform B (PR-B) in Endometriosis via openalex
- Suppression of IL-1β-induced COX-2 expression by trichostatin A (TSA) in human endometrial stromal cells via openalex
- The elusive adenomyosis of the uterus—revisited via openalex
- The induction of adenomyosis in mice by intrauterine pituitary isografts via openalex
- [The morphological and immunohiochemical features of foci of adenomyosis: in its concurrence with endometrial adenocarcinoma]. via openalex
- Trichostatin A, a Histone Deacetylase Inhibitor, Attenuates Invasiveness and Reactivates E-Cadherin Expression in Immortalized Endometriotic Cells via openalex
- Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice via openalex
- W4406058850 via openalex
- W250209819 via openalex
- W1503834335 via openalex
- W1973217858 via openalex
- W2024125959 via openalex
- W2032741636 via openalex
- W2038354928 via openalex
- W2040418863 via openalex
- W2054469649 via openalex
- W2058170926 via openalex
- W2078879971 via openalex
- W2079078286 via openalex
- W2108328978 via openalex
- W2110385915 via openalex
- W2132187713 via openalex
- W2135575116 via openalex
- W2145273862 via openalex
- W2155524482 via openalex
- W2162983470 via openalex
- W2164385268 via openalex
- W2236268895 via openalex
- W2321413400 via openalex
- W2582743722 via openalex
- W4254901254 via openalex
Cited by (40)
- Drug development for adenomyosis based on pathophysiology 2025
- Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies 2024
- Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies 2024
- Adenomyosis and Infertility: A Literature Review 2023
- Aberrant expression of histone deacetylase 8 in endometriosis and its potential as a therapeutic target 2023
- The Present and the Future of Medical Therapies for Adenomyosis: A Narrative Review 2023
- Corroborating evidence for aberrant expression of histone deacetylase 8 in endometriosis 2023
- The Role of Platelets in the Pathogenesis and Pathophysiology of Adenomyosis 2023
- Adenomyosis and Infertility: A Literature Review 2023
- Pathogenesis of Human Adenomyosis: Current Understanding and Its Association with Infertility 2022
- Neonatal feeding of an estrogen receptor β agonist induces external adenomyosis-like lesions in ICR mouse 2022
- Neonatal feeding of an estrogen receptor β agonist induces external adenomyosis-like lesions in ICR mouse 2022
- Medical Treatment of Adenomyosis 2022
- Cracking the enigma of adenomyosis: an update on its pathogenesis and pathophysiology 2022
- Immune cells and Notch1 signaling appear to drive the epithelial to mesenchymal transition in the development of adenomyosis in mice 2021
- Shi Xiao San ameliorates the development of adenomyosis in an ICR mouse model 2020
- An Update on the Various Theories of the Origin of Uterine Adenomyosis –A Systematic Review 2020
- Adenomyosis: Mechanisms and Pathogenesis 2020
- Animal Models of Adenomyosis 2020
- A critical review of recent advances in the diagnosis, classification, and management of uterine adenomyosis 2019
- Pathogenesis of uterine adenomyosis: invagination or metaplasia? 2018
- Quercetin alleviates generalized hyperalgesia in mice with induced adenomyosis 2017
- Leonurine Attenuates Hyperalgesia in Mice with Induced Adenomyosis 2017
- Pathogenesis of adenomyosis: an update on molecular mechanisms 2017
- Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis 2016
- Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis 2016
- Anti-platelet therapy holds promises in treating adenomyosis: experimental evidence 2016
- Resveratrol Reduces Myometrial Infiltration, Uterine Hyperactivity, and Stress Levels and Alleviates Generalized Hyperalgesia in Mice With Induced Adenomyosis 2015
- The Endometrium in Adenomyosis 2015
- Improving the Preclinical Mouse Efficacy Studies of Adenomyosis 2015
- Adenomiosis: tratamiento 2015
- Possible Loss of GABAergic Inhibition in Mice With Induced Adenomyosis and Treatment With Epigallocatechin-3-Gallate Attenuates the Loss With Improved Hyperalgesia 2014
- Structural and molecular features of the endomyometrium in endometriosis and adenomyosis 2013
- Methodological Issues in Preclinical Mouse Efficacy Studies of Adenomyosis 2012
- The Endometrium in Adenomyosis 2012
- Aberrant Immunoreactivity of Deoxyribonucleic Acid Methyltransferases in Adenomyosis 2012
- Dysmenorrhea and its severity are associated with increased uterine contractility and overexpression of oxytocin receptor (OTR) in women with symptomatic adenomyosis 2012
- Elevated Immunoreactivity against Class I Histone Deacetylases in Adenomyosis 2012
- Histone deacetylase inhibitors as therapeutics for endometriosis 2012
- The Epigenetics of Endometriosis 2012
Source provenance
- europepmc
- last seen: 2026-08-28T06:11:01.063540+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:16:42.478857+00:00
- unpaywall
- last seen: 2026-08-27T06:26:25.619941+00:00
License: CC0
· commercial use OK